We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

BioPharma Credit plc (BPCR) ORD USD0.01

Sell:$0.87 Buy:$0.87 0 Change: $0.01 (1.14%)
Market closed Prices as at close on 8 October 2024 Prices delayed by at least 15 minutes | Switch to live prices |
Ex-dividend
Sell:$0.87
Buy:$0.87
Change: $0.01 (1.14%)
Market closed Prices as at close on 8 October 2024 Prices delayed by at least 15 minutes | Switch to live prices |
Ex-dividend
Sell:$0.87
Buy:$0.87
Change: $0.01 (1.14%)
Market closed Prices as at close on 8 October 2024 Prices delayed by at least 15 minutes | Switch to live prices |
Ex-dividend
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.
Open:
$0.87
Trade high:
$0.89
Year high:
$0.94
Estimated NAV:
99.19
Previous close:
$0.88
Trade low:
$0.87
Year low:
$0.81
Premium/Discount:
-11.08%
Previous:
$0.00 (0.23%)
Previous:
$0.00
Volume:
1,001,016
Dividend yield:
8.05%
Currency:
USD
Data delayed by at least 15 minutes.

Price

  • Net Asset Value (NAV)
BIOPHARMA CRED. performance chart

Premium/Discount

BIOPHARMA CRED. performance chart
Full interactive share price and premium / discount charts

Performance

1 week 1W 3.72% 1 year 1Y 2.8%
1 month 1M 4.35% 2 years 2Y 6.18%
3 months 3M 3.04% 3 years 3Y 10.02%
6 months 6M 0.23% 5 years 5Y 13.3%

Performance figures are based on the previous close price. Past performance is not an indication of future performance.

Trust Basics

Benchmark: No benchmark
Annual management charge: 1% of Net Assets
Performance fee: Yes
Ongoing charge: 1.14%
Dividend yield: 8.05%
Dividend frequency: Quarterly
Total assets: £1,185m
Gross gearing: 0%
Market capitalisation:Market cap.: £1,054m
Shares in issue: 1.19 bn
Legal structure Closed Ended Investment Company
Domicile: United Kingdom
ISIN GB00BDGKMY29

Recent dividends paid or declared by BioPharma Credit plc:

Type Ex-div date Payment date Amount
3rd interim * 26/09/2024 29/10/2024 1.75¢
Special * 26/09/2024 29/10/2024 2.04p
2nd interim 04/07/2024 31/07/2024 1.75¢
1st interim 28/03/2024 30/04/2024 1.75¢
Special 15/02/2024 15/03/2024 1.2079¢

* Dividend has not yet been paid but has been declared by BioPharma Credit plc.

This data is provided by Digital Look. HL accepts no responsibility for its accuracy and you should independently check data before making any investment decision.

Full dividend history

Five years' total annual BioPharma Credit plc dividends:

Financial
year end
Dividend
yield
Dividend
cover
Total dividend
paid
31/12/2023 8.30% 1.44 $0.07
31/12/2022 7.40% 1.85 $0.1
31/12/2021 7.20% 1.13 $0.07
31/12/2020 7.00% 0.83 $0.07
31/12/2019 6.90% 1.18 $0.07

All dividend data is calculated excluding any special dividends. Historical dividends may be adjusted to reflect any subsequent rights issues and corporate actions.

Full dividend history

Ready to invest?

Invest now

Want to invest?

To buy shares in , you'll need to have an account.

Explore the options

Important Documents



Objective

To generate long-term shareholder returns, predominantly in the form of sustainable income distributions from exposure to the life sciences industry. The Company will seek to achieve its investment objective predominantly through direct or indirect exposure to Debt Assets, which include Royalty Investments, Senior Secured Debt, Unsecured Debt and Credit Linked Notes.

NET ASSET VALUE (NAV)

Estimated NAV: $99.19
Latest actual NAV: $76.59
Latest actual NAV date: 31 August 2024
Premium/Discount: -11.08%
12m average Premium/Discount: -12.21%
NAV frequency: Monthly
Security Weight
Collegium 18.98%
Lumira Dx 11.34%
Insmed Inc 11.00%
Coherus 9.41%
BioCryst Pharmaceuticals Inc 9.15%
Bms 6.75%
OptiNose Inc 5.38%
Evolus 3.77%
Urogen 3.77%
Immunogen Inc 2.82%

Top 10 sectors currently unavailable.

Country Weight
United States 28.36%

Key Dates

Launch date: 22 March 2017
Financial year end: December
Next AGM: May 2025
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Prices provided by NBTrader. Charts provided by Factset. Dividend data provided by Digital Look. Recent trade data provided by MoneyAM. Trust basics, holding data, key dates, objective and NAV provided by Morningstar.

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.